Eirini Schlosser is the CEO of Dyania Health, a fast-growing technology company focused on applying clinical natural language processing to pre-screening concurrent and retrospective EMR's for use in patient trial enrollment or in synthetic studies and external control arms. She is a serial entrepreneur and has spent the last decade building and leading data science and natural language processing applications. She founded Dyania Health in 2019 and has built a team of engineers, scientists and principal investigators from UCLA Health, Harvard, Regeneron, J&J, Amazon,Northwell Health, and Kite Pharma / Gilead. In addition to professional certifications in machine learning from MIT and a Masters degree from London Business School, her prior experience includes working on approx. $60 billion deal value in technology, pharmaceutical, and consumer transactions as a member of Morgan Stanley’s Mergers & Acquisitions Team.